Syros pharmaceuticals ticker

Author: qcvx

August undefined, 2024

WebJul 5, 2024 · CAMBRIDGE, Mass. & BEDMINSTER, N.J.-- (BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. (NASDAQ:TYME), today announced that the companies have entered into a definitive merger agreement pursuant to which Syros … WebA. While ratings are subjective and will change, the latest Syros Pharmaceuticals ( SYRS) rating was a maintained with a price target of $15.00 to $13.00. The current price Syros Pharmaceuticals ...

Syros Pharmaceuticals, Inc. (SYRS) - Stock Analysis

WebApr 6, 2024 · The Syros Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human … WebFollowing my experience in 2016, I was invited to apply for the expo of 2024. Again I worked directly under the team that managed, organised and ran … the way i hate you kdrama

Syros Pharmaceuticals, Inc. (SYRS)

WebSyros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The … WebThe price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company). WebSyros Pharmaceuticals ( NASDAQ:SYRS ) Full Year 2024 Results Key Financial Results Revenue: US$14.9m (down 37% from FY... Q4 2024 Syros Pharmaceuticals Inc Earnings … the way i heard it episode 124

Syros Pharmaceuticals (SYRS) Latest News & Price InvestorPlace

WebMar 24, 2024 · Syros Pharmaceuticals - SYRS - Stock Price Today - Zacks Syros Pharmaceuticals (SYRS) (Delayed Data from NSDQ) $2.74 USD -0.07 (-2.49%) Updated … WebMar 31, 2024 · Syros Pharmaceuticals, Inc. Price and Consensus Syros Pharmaceuticals, Inc. Quote. Bottom Line. The stock has also started to move higher lately, adding 36.8% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to ... the way i heard it mike roweWebApr 10, 2024 · Ticker Symbol SYRS Full Company Profile Financial Performance In 2024, SYRS's revenue was $14.88 million, a decrease of -36.65% compared to the previous … the way i heard it podcast episode list

"WebApr 12, 2024 · Myelodysplastic Syndrome Epidemiology Insights. The total incident population of MDS in the 7MM was 41,850 in 2024, growing at a CAGR of 0.6% during the study period (2024–2032). " - Syros pharmaceuticals ticker

Syros pharmaceuticals ticker

Syros Announces Closing of Merger with Tyme Technologies and …

WebFind real-time SYRS - Syros Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SYRS - Syros Pharmaceuticals Inc Stock quote - … WebSyros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control …

Did you know?

WebSyros Pharmaceuticals, Inc. (SYRS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets open in 6 hours 59 minutes Dow Futures Nasdaq Futures Russell 2000 Futures … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo … Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Syros Pharmaceuticals, … Find out the direct holders, institutional holders and mutual fund holders for … See the company profile for Syros Pharmaceuticals, Inc. (SYRS) including … See Syros Pharmaceuticals, Inc. (SYRS) stock analyst estimates, including … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call … Find out all the key statistics for Syros Pharmaceuticals, Inc. (SYRS), including … View the basic SYRS option chain and compare options of Syros … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and … WebApr 10, 2024 · Support: 888-992-3836 Home NewsWire Subscriptions ...

WebC/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE (Street) CAMBRIDGE MA 02140 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Syros Pharmaceuticals, Inc. [ SYRS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief … WebQuote :: Syros Pharmaceuticals, Inc. (SYRS) Quote Do you want to load external content supplied by QMod Stock Tools? Market Data copyright © 2024 QuoteMedia. Data delayed …

WebMar 2, 2024 · 98,4%. More Financials. Company. Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on redefending the power of small molecules to control the expression of genes. The Company is engaged in developing treatments for cancer and diseases resulting from mutations of a single gene, also known …

WebSyros Pharmaceuticals has raised a total of $525.5M in funding over 9 rounds. Their latest funding was raised on Jul 5, 2024 from a Post-IPO Equity round. Syros Pharmaceuticals is registered under the ticker NASDAQ:SYRS . Their stock opened with $12.50 in its Jun 30, 2016 IPO. Syros Pharmaceuticals is funded by 18 investors. the way i heard it episode listWebMar 2, 2024 · Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with … the way i heard it book reviewWebWe are focused on applying this approach to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded current targeted approaches, we are advancing our late-stage clinical pipeline to provide new treatment options. the way i heard it mike rowe podcastWebDiscover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or monthly format back to when Syros Pharmaceuticals, Inc. stock was issued. the way i heard it bookWebStock analysis for Syros Pharmaceuticals Inc (SYRS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. the way i heard it podcast mike roweWebOct 3, 2024 · Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today. By William White, InvestorPlace Writer Dec 18, 2024. Syros Pharmaceuticals (SYRS) news for Wednesday about plans for ... the way i heard it mike rowe bookWebApr 4, 2024 · Syros Pharmaceuticals. stock was originally listed at a price of $181.50 in Jun 30, 2016. If you had invested in Syros Pharmaceuticals stock at $181.50 , your return over … the way i heard it youtube